Vanguard Group Inc Invitae Corp Transaction History

Vanguard Group Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.42 - $0.72 $475,711 - $815,505	1,132,646 Added 8.37%	14,660,153 $9.24 Million
Q3 2023 Nov 14, 2023	BUY	$0.6 - $1.53 $211,842 - $540,198	353,071 Added 2.68%	13,527,507 $8.12 Million
Q2 2023 Aug 14, 2023	SELL	$1.05 - $1.63 $5.42 Million - $8.41 Million	-5,161,831 Reduced 28.15%	13,174,436 $14.9 Million
Q1 2023 May 15, 2023	SELL	$1.2 - $2.73 $5.1 Million - $11.6 Million	-4,251,688 Reduced 18.82%	18,336,267 $24.8 Million
Q4 2022 Feb 10, 2023	BUY	$1.71 - $3.61 $1.65 Million - $3.48 Million	963,601 Added 4.46%	22,587,955 $42 Million

Q3 2022 Nov 14, 2022	BUY	$1.9 - $8.63 $1.04 Million - $4.7 Million	544,941 Added 2.59%	21,624,354 $53.2 Million
Q2 2022 Aug 12, 2022	BUY	$2.13 - $9.01 $3.33 Million - $14.1 Million	1,563,827 Added 8.01%	21,079,413 $51.4 Million
Q1 2022 May 13, 2022	BUY	$6.28 - $15.59 $437,728 - $1.09 Million	69,702 Added 0.36%	19,515,586 $156 Million
Q4 2021 Feb 14, 2022	BUY	$14.7 - $28.67 $11.4 Million - $22.3 Million	777,561 Added 4.17%	19,445,884 $297 Million
Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $33.3 Million - $46.1 Million	1,371,600 Added 7.93%	18,668,323 $531 Million
Q2 2021 Aug 13, 2021	BUY	$26.09 - $40.4 $451 Million - $699 Million	17,296,723 New	17,296,723 $583 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.